16 results
10-K
2023 FY
IMCR
Immunocore Holdings plc
28 Feb 24
Annual report
7:33am
and safety for the donation, procurement, testing, processing, preservation, storage and distribution of human tissues and cells, or the Tissues and Cells
20-F
2020 FY
IMCR
Immunocore Holdings plc
25 Mar 21
Annual report (foreign)
7:01am
relating to our procurement processes and application of delegation of authority approval limits due to insufficient risk assessment procedures. Since … processes and procurement controls, implementing improvements in software relating to approvals of purchase orders and contracts, adding additional layers
424B4
IMCR
Immunocore Holdings plc
8 Feb 21
Prospectus supplement with pricing info
8:36am
. As a result of this investigation, we identified a material weakness in our internal controls relating to our procurement processes and application … identified a material weakness relating to our procurement processes and application of delegation of authority approval limits due to insufficient risk
F-1/A
0cp704l3vt6nz88
3 Feb 21
Registration statement (foreign) (amended)
5:22pm
F-1/A
at7iu3qk
1 Feb 21
Registration statement (foreign) (amended)
6:21am
F-1
EX-10.14
pe5v7q20d
15 Jan 21
Registration statement (foreign)
4:57pm
F-1
EX-10.13
mfvmo
15 Jan 21
Registration statement (foreign)
4:57pm
F-1
qregh
15 Jan 21
Registration statement (foreign)
4:57pm
F-1
EX-10.15
1ly04 v3qvecw24
15 Jan 21
Registration statement (foreign)
4:57pm
DRS/A
EX-10.14
7p5kunq
22 Dec 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.12
m4ho4sk
22 Dec 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.13
czo5tijhs gabrmewh7
22 Dec 20
Draft registration statement (amended)
12:00am
DRS/A
qgawyqmqr 9qfj
19 Nov 20
Draft registration statement (amended)
12:00am
DRS
3d02evj31w3arp 71
17 Nov 20
Draft registration statement
12:00am
- Prev
- 1
- Next